Silverberg Bernstein Capital Management’s VolitionRx Ltd VNRX Stock Holding History

Silverberg Bernstein Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9K	Sell	12,520 -41	-0.3%	-$99	0.01%	70
2026 Q1	$50.7K	Buy	12,561 +97	+0.8%	+$463	0.03%	67
2025 Q4	$63.7K	Buy	12,464 +860	+7%	+$6.53K	0.04%	65
2025 Q3	$157K	Buy	11,604 +1,565	+16%	+$20.8K	0.1%	62
2025 Q2	$153K	Buy	10,039 +3,010	+43%	+$33.2K	0.1%	61
2025 Q1	$80.1K	Buy	7,029 +333	+5%	+$3.97K	0.07%	59
2024 Q4	$80.3K	Sell	6,696 -435	-6%	-$5.84K	0.07%	51
2024 Q3	$85.7K	Sell	7,131 -100	-1%	-$1.29K	0.08%	50
2024 Q2	$87.5K	Hold	7,231	–	–	0.08%	50
2024 Q1	$109K	Sell	7,231 -121	-2%	-$2.37K	0.11%	51
2023 Q4	$105K	Buy	+7,352	New	+$108K	0.1%	50

Other funds holding VNRX

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Silverberg Bernstein Capital Management's VNRX Position: Q2 2026 in Review

Silverberg Bernstein Capital Management reduced its VolitionRx Ltd (VNRX) stake by 0.33% in Q2 2026, selling an estimated $99 and leaving 12,520 shares worth $16.9K. The position accounts for 0.01% of the portfolio, ranked #70.

Silverberg Bernstein Capital Management first reported a position in VNRX in Q4 2023 and has held it in 11 quarters since. The position peaked at $157K in Q3 2025. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

Silverberg Bernstein Capital Management held 12,520 shares of VolitionRx Ltd worth $16.9K as of Q2 2026.
Silverberg Bernstein Capital Management sold 41 VolitionRx Ltd shares in Q2 2026, an estimated $99.
VolitionRx Ltd made up 0.01% of Silverberg Bernstein Capital Management's portfolio in Q2 2026, its #70 holding.
Silverberg Bernstein Capital Management first reported a position in VolitionRx Ltd in Q4 2023 and has held it in 11 quarters since.
Silverberg Bernstein Capital Management's VolitionRx Ltd position peaked at $157K in Q3 2025.
19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Silverberg Bernstein Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.